Company intelligence / Profile preview

SCINTOMICS Molecular, Applied Theranostics Technologies

Fürstenfeldbruck, Bavaria, Germany
Ownership
Private
Development stage
Other
01

Overview

SCI-att is the radiopharmaceutical tools and precursor subsidiary of Scintomics, supplying GMP and R&D precursors (e.g., PSMA I&T, SiFAlin-TATE, next‑generation PSMA inhibitors) and operating the GRP radiosynthesis platform used in routine clinical production of PET/SPECT tracers worldwide; its technologies underpin clinically developed radiohybrid PSMA and CXCR4 theranostic tracers that have reached late-stage clinical development and regulatory approval via licensees such as Blue Earth Diagnostics and others.[1][2][4][7][9][10]

Therapeutic areas
OncologyCardiovascularHematology
Modalities
RadiopharmaceuticalSmall molecule
Industry
Contract Manufacturing Organization
02

Partnerships

International Isotopes (distribution and service of GRP radiosynthesis platform in US and Canada)[5]Eckert & Ziegler Eurotope (CMO for GRP disposable cassettes)[7]

Beyond the preview

Go deeper on SCINTOMICS Molecular, Applied Theranostics Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCINTOMICS Molecular, Applied Theranostics Technologies.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call